chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt was given second dose of Pfizer vaccine on 6/1/2021 at 1050, pt complained of feeling dizzy, lightheadedness, and diaphoretic at 1057. Pt was observed- pt was pale, diaphoretic, drowsy but arousable, pt oriented x4. Vital signs were taken immediately: BP 62/33 (44), HR41, SpO297% RA, vital signs were repeated at 1105 as followed BP 68/28 (41), HR 41, SpO2 97% RA. RN STAT and 911 were called. Ice pack was applied to back of neck, ammonia was used for pt to smell, pt states he had breakfast in the morning but did not drink a lot of water. RN tried to take manual BP, attempted twice, unable to obtain bp. RN STAT nurse arrived, report given to RN STAT, pt placed in gurney to be taken down to treatment room.    At treatment room, pt looked "regained his color, not as pale as before" according to patient's mother. Mother at bedside throughout whole event. Vital signs were taken once arrival to treatment room at 1116: 117/41 (72), HR50, SpO2 97%. EMS arrived to treatment room, EKG taken- sinus bradycardia shown on screen, pt's mother unable to verify pt's resting HR. Pt states he is an athlete, runs track in school. Blood glucose 98.  Pt stated he felt back to normal, mother said she would monitor him from home.
Heart palpitations, diarrhea, nausea, cramps, headache, neck sensation, tinnitus, muscle soreness (myalgia), chills, slight fever, sore throat, congestion, injection site pain
Severe back pain, tingling, loss of feeling in legs;  Ketosis; 2 emergency room visits, MRIs, CAT Scans, X-rays.
large hives all over body appeared day after vaccination and continued for 3 days.  Mom treated day 1 with benadryl then oral steroids when didn't resolve.
No additional adverse events reported; The nurse stated on 7/28/2020 she administered and expired VAQTA; This spontaneous report as received from a nurse via company representative and refers to a 2-year-old patient of unknown gender. The patient's medical history, historical drugs, previous drug reactions, allergies, concurrent conditions, and concomitant therapies were not reported.  On 28-JUL-2020, the patient was vaccinated with and expired dose of hepatitis a vaccine, inactivated (VAQTA), expiration date on 26-JUL-2020 as prophylaxis. (strength, dose, frequency, route of administration, anatomical location, and lot number not reported). No additional adverse event reported.
I had a sore throat, drainage, body aches, headaches, fatigue, and dizziness. This lasted for about 11 days. It would go away and come back. I started to lose my voice towards the end of it. I was not prescribed medication. I took over-the-counter Mucinex and Zyrtec.
Shingles outbreak on my face and in my eye. Flu like symptoms for 2 days after 2nd shot and then tingling/itching on my face day 3. Day 4 small bumps. Day 5 painful rash and swollen face. Day 6 and currently painful rash all over face, eye is swollen shut and shingles are now appearing on back and one blister on stomach. Everything is on the right side.
Hot arm; Arm swelling; Red arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot arm), PERIPHERAL SWELLING (Arm swelling) and ERYTHEMA (Red arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot arm), PERIPHERAL SWELLING (Arm swelling) and ERYTHEMA (Red arm). At the time of the report, VACCINATION SITE WARMTH (Hot arm), PERIPHERAL SWELLING (Arm swelling) and ERYTHEMA (Red arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 as dose 4 (booster), single (Lot number: GH9703) at the age of 36 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 25Mar2021 as dose 1, single (Lot number: ER8730), on 22Apr2021 as dose 2, single (Lot number: ER8731) and on 03Dec2021 as dose 3 (booster), single (Lot number: FJ8762) for covid-19 immunisation. The patient's relevant medical history included: "IUD" (unspecified if ongoing). Concomitant medication(s) included: SPIRONOLACTONE; MIRENA; EMGALITY [GALCANEZUMAB]. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11Dec2022) Positive, notes: four days after completing Paxlovid course. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional information: The patient took paxlovid for COVID 19 treatment from 03Dec2022 to 08Dec2022. Return of covid symptoms/positive test results four days on 11Dec2022 after completing Paxlovid course. Patient had no known allergies and no other medical history.
This spontaneous report was received from a registered nurse and refers to a patients of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown dates, the patients were vaccinated with an improperly stored dose GARDASIL 9, lot number M021407, expiration date 30-APR-2018, intramuscularly (dose, and anatomical location were not reported) for prophylaxis (incorrect product storage). The vaccine was exposed to temperature of 46 Fahrenheit (F) (7,7 Celsius(C)) and to the highest recorded temperature of 77 F (25C) during 240 hours. No storage type "data logger" was reported. There was no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
Fever, extreme migraine lasting more than 24 hours.  The worst pain I have ever felt.
Pea sized nodule at hair line left side of neck for 3 days. Small amount of vesicular rash on body- no fever.
Painful and red injection site,  body aches, chills, headache, nausea, fatigue, unable to sleep the night after the shot.
Patient was administered the 1st dose of the Moderna COVID-19 vaccine. Current program is only for those 18 years and over. The patient was 17 years and 2 months old at the time of administration. She was otherwise eligible for the vaccine due to her employment as a restaurant worker.
When 1st hepatitis B vaccine given, she experienced lightheadedness and fainting. Within a week she had a slight sore throat, swollen glands. This also occurred with 2nd dose. I did not make her get the 3rd dose. No treatment given She has also chronic fatigue. Medical records state headache.
CONSTANT DIZZINESS; WEAKNESS TO THE POINT OF CONCERN; This spontaneous report received from a patient concerned an 87 year old female. The patient's height, and weight were not reported. The patient's past medical history included cardiac arrest, and concurrent conditions included chronic obstructive pulmonary disease, diabetes, high blood pressure, and henoch-schonlein purpura. The patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 04-MAY-2021 19:00:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 07-MAY-2021, the subject experienced dizziness. On 07-MAY-2021, the subject experienced weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness, and weak. This report was non-serious.
box labeled with lot P5572, recall per GSK documentation. GSK was called, pharmaceutical company employee indicates it is not a question of quality. but off abel lettering.
Child had apneic and listless type episode approx 1/2 hour after vaccine given. Did wake up after being removed from car but then she had another episode. Child seemed excessively drowsy at the time.
Pt. had a white colored area around injection site (right arm). Also accompanied by itching and extreme redness on arm surrounding white patch of skin.
Patient developed Croup 3 days following Flu Mist vaccine and required an Emergency room visit due to stridor and a course of Prednisone
Right arm with large 6 inch circle of swollen and red  and hot to the touch with soreness and itching  similar to hives
Suicidal ideation which turned into a two week stay for "psychosis" and then a month-long stay and treatment in the hospital for "Acute Disseminated Encephalomyelopathy.
Pt. had a seizure about 3 wks. after receiving shots. He had a fever of 99.6 before going into seizure.
9:50 am- patient's mother called school office to report that he had an allergic reaction to vaccines that were given on HRE today around 9:15. Patient had IPV #4, DTaP #5, MMR II, Var #2, and PPD today. Left message for mom to call us re: his status. 12:15 pm-patient's mom brought him back to medical center to report what happened. He developed chest tightness, tingling in his fingers, and "hot" hands, and swollen face about 20 minutes after immunization. Mo. took him to medical center where they gave him Epi Pen injection, O2 and called 911. Paramedics took him to hospital where they observed him and discharged him home with Benadryl po and recommended that he be evaluated by an allergist. Mo. states they do have insurance and will go to PCP to get an allergic referral.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 02Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 66 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "COPD" (unspecified if ongoing); "CHF" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
15 minutes post vaccine stated to feel scratchy throat, "funny to swallow" Benadryl 25 mg PO was given. 17:50 repeat dose given Benadryl 25 mg PO. 1805- symptoms improving, VS stable.  1815- Felt well enough to go home, discharged to home.
pt to ER w/varicella-like rash on chest p/recv varicella vax 10 days prior;
diarrhea; vomiting; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (diarrhea), VOMITING (vomiting) and MYALGIA (sore arm) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced DIARRHEA (diarrhea), VOMITING (vomiting) and MYALGIA (sore arm). On 16-Mar-2021, DIARRHEA (diarrhea), VOMITING (vomiting) and MYALGIA (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided   This case was linked to MOD21-075780, MOD21-075706, MOD-2021-077211, US-MODERNATX, INC.-MOD-2021-076718, US-MODERNATX, INC.-MOD-2021-076812 (E2B Linked Report).; Sender's Comments:  MOD21-075780: MOD21-075706: MOD-2021-077211:second case US-MODERNATX, INC.-MOD-2021-076718:Same reporter US-MODERNATX, INC.-MOD-2021-076812:Dose 2
Wheezing, difficulty of breathing, edema eyelids; none then monitored after 1 hour.  Rx 1 epinephrine, albuterol.  2 Referred to ER by paramedics; Benadryl.
This spontaneous report as received from a healthcare worker refers to unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX, (dose route, lot # and expiration date were not provided). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
a year for the last one my doctor explains to me very well so is time for my second one; This case was reported by a consumer via media and described the occurrence of drug schedule prescribing error in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles, crying (day and night), pain (really hurt), burn and pruritus.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced drug schedule prescribing error. On an unknown date, the outcome of the drug schedule prescribing error was unknown.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The age group of patient was not reported however was captured as an adult as per vaccine indication. The patient reported that he/she had shingles in past. The patient was crying day and night and stated that that's really hurt and reported about itch and burn. The patient hope that he/she never got it again, so patient got the first shot of vaccine. The patient stated that his/her physician explained that patient need second dose after 6 months and 3rd dose after a year, which led to drug schedule prescribing error.  No other information was reported.
Pt vax w/ hepta B on 02Aug90, 05Sep90, 16Oct90.  Jan 1991 titers - zero.
Information has been received from the VAERS database via a journalist. This spontaneous report as received from a other refers to a patient of unknown age. The patient was vaccinated with lot # (656412/1476F) ZOSTAVAX on 11-SEP-2007. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced herpes zoster. No treatment information was reported. The outcome of herpes zoster is unknown. The relatedness for herpes zoster is unknown for ZOSTAVAX. Additional information is not expected.
54 yo F received 2nd dose of Pfizer Covid vaccine and immediately reported face numb, throat tingling, and throat feeling sticky. 25mg of Benadryl was immediately administered, and EMS called. Epi pen was administered once and again approximately 10 minutes later when EMS has not yet arrived and patient was still reporting sticky throat. EMS arrived and patient was transferred to a hospital.
Patient calling to report that she developed fatigue, redness, swelling and pain in her left arm, axillary area and along her left side after having both the flu vaccine and Pneumovax in her left arm on 10/17. Patient states her symptoms have now started to decrease and she is feeling better today.
Pain in lower abdomen; Pain in lower back; Bowel "spurts"; Developed a Urinary Tract Infection; Vision & hearing dimmed; Vision & hearing dimmed; Behavior changed, not acting normal; Developed a headache for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Vision & hearing dimmed), VISUAL IMPAIRMENT (Vision & hearing dimmed), ABNORMAL BEHAVIOUR (Behavior changed, not acting normal), ABDOMINAL DISCOMFORT (Bowel "spurts") and URINARY TRACT INFECTION (Developed a Urinary Tract Infection) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy, Blood pressure high, Thyroid disorder, Drug allergy (amoxicillin), Drug allergy (ampicillin) and Drug allergy (ciprofloxacin).    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced HYPOACUSIS (Vision & hearing dimmed), VISUAL IMPAIRMENT (Vision & hearing dimmed), ABNORMAL BEHAVIOUR (Behavior changed, not acting normal) and HEADACHE (Developed a headache for a couple of days). On 11-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Bowel "spurts") and URINARY TRACT INFECTION (Developed a Urinary Tract Infection). On 02-Apr-2021, the patient experienced ABDOMINAL PAIN LOWER (Pain in lower abdomen) and BACK PAIN (Pain in lower back). At the time of the report, HYPOACUSIS (Vision & hearing dimmed), VISUAL IMPAIRMENT (Vision & hearing dimmed), ABNORMAL BEHAVIOUR (Behavior changed, not acting normal), ABDOMINAL DISCOMFORT (Bowel "spurts"), URINARY TRACT INFECTION (Developed a Urinary Tract Infection), ABDOMINAL PAIN LOWER (Pain in lower abdomen), BACK PAIN (Pain in lower back) and HEADACHE (Developed a headache for a couple of days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 4/23/2022 LUNG ABSCESS J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/23/2022 LUNG ABSCESS J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 4/23/2022 INTERSTITIAL LUNG DISEASE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/23/2022 INTERSTITIAL LUNG DISEASE J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 4/23/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/23/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 4/23/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/23/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 4/23/2022 CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/23/2022 CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 4/23/2022 CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/23/2022 CHRONIC HYPOXEMIC RESPIRATORY FAILURE
inflammation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 42-year-old male patient received BNT162b2 (BNT162B2), on 13Dec2021 as dose 3 (booster), single (Lot number: FD0809) at the age of 41 years for covid-19 immunisation. The patient's relevant medical history included: "monkey pox" (unspecified if ongoing), notes: Got in this Jun and had monkey pox and felt like getting better after 3 weeks; "COVID", start date: Jan2020 (unspecified if ongoing), notes: tested positive once and the first time was Jan2020; "COVID", start date: Apr2020 (unspecified if ongoing), notes: They got delta in late Apr2020 and not yet vaccinated.; "Hydrocele like a build of lymphatic fluid in the scrotum" (unspecified if ongoing), notes: Hydrocele like a build of lymphatic fluid in the scrotum; "Covid-19" (unspecified if ongoing), notes: They had covid several times; "Long covid" (unspecified if ongoing), notes: she had long Covid and lost sense of smell and all the symptoms with the first round of Covid. Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; MELATONIN; PEPCID [FAMOTIDINE]; REISHI MUSHROOM; TURKEY TAIL MUSHROOM; VITAMIN C [ASCORBIC ACID]; MAGNESIUM. Vaccination history included: BNT162b2 (Lot: EW0175), administration date: 27Apr2021, when the patient was 40-year-old, for COVID-19 Immunization; BNT162b2 (Lot: EW0183), administration date: 19May2021, when the patient was 41-year-old, for COVID-19 Immunization.  The following information was reported: INFLAMMATION (non-serious), outcome "not recovered". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of inflammation. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201204867 similar report from same reporter.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A patient of unspecified age, race, ethnicity and gender received TRUMENBA at single dose via an unspecified route of administration on an unspecified date for immunization. The patient medical history and concomitant medications were not reported. The patient had sudden seizure type event, felt weak and had headache for number of days following vaccine administration, was pale and had chills. Outcome was unknown. The information on the batch number has been requested. Sender's Comments: This case is poorly documented. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.
Myocarditis; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). A 15 year-old patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Reporter did not want the vaccine, states it is his body and his choice. His friend's 15 year old kid (patient) died from the COVID vaccine from myocarditis. States that Pfizer needs to stop pressuring people to take the vaccine since people don't want the vaccine. It is not safe for kids. He declined to go through a report or provide contact details, stating then the government would come after him. States to stop hiding the data. He continued to talk over call handler and informed him the call would be disconnected since he declined to go through report. It was unknown if autopsy was done. Outcome of the event was fatal on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: myocarditis
MODERNA PRIME VACCINE WAS GIVEN INSTEAD OF MODERNA BIVALENT Patient received his first dose of covid vaccine Janssen 5/19/21 Lot # 1805031
pt recvd vax; infant became pallid,clammy,turned blue & had sz;mom reportes caretaker & pt taken to er;